Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Access expired on Thursday, November 14, 2019

This content was originally shared by a registered user, but access has expired. Create a free account to gain permanent access to all PracticeUpdate content.

Already Have An Account? Log in Now

featured
Published in Oncology

Expert Opinion / Interview · October 15, 2019

Nivolumab vs Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma

Interview by
Daniel Catenacci MD
Interview with
Elizabeth Smyth MD

 

Further Reading